Leveraging an academic-industry partnership to develop a cancer-specific mobile meditation app - 1 Project Summary/Abstract
2 Approximately 15.5 million US cancer patients/survivors experience a host of residual symptoms (e.g.,
3 fatigue, anxiety, depression, pain, sleep disturbance) and reduced quality of life that are often not resolved with
4 even the best-available current standard of care therapies. Residual symptom burden impairs cancer survivor
5 functioning and leads to increased rates of disability and healthcare utilization, costing $125 billion every year.
6 Cancer patients/survivors want and need complementary strategies to accompany standard therapies.
7 Research has demonstrated the benefits of mindfulness-based therapies, such as meditation, for
8 alleviating cancer-related symptoms (e.g., fatigue, anxiety, depression, and sleep disturbance).Meditation-based
9 programs are typically conducted in-person, in clinic settings; however, these programs are expensive and
10 difficult to sustain, and cancer patients report barriers to participating (e.g., travel demands, fatigue, pain, and
11 scheduling difficulties). Smartphone-based meditation is a feasible and novel method for delivering meditation
12 to cancer patients/survivors. Mobile apps and online meditation programs have demonstrated short-term benefits
13 for cancer patients/survivors; however, the currently available commercial meditation apps are limited in their
14 engagement, acceptability, and applicability to cancer patients/survivors’ unique experiences and have not been
15 evaluated for feasibility or efficacy. There is an unmet need for a commercially-available, evidence-based
16 meditation app specifically designed for cancer patients/survivors. Incorporating stakeholder feedback (i.e.,
17 patients and healthcare providers) in the early design phase will facilitate the development of a meditation app
18 truly targeted for the end users that can be made commercially available, thereby improving uptake and impact
19 in patient populations. Calm, a popular consumer-based meditation app with 70 million downloads and 2 million
20 subscribers, provides a platform from which to develop an accessible standalone cancer-specific meditation app.
21 This project will: 1) gather feedback about the current Calm app from an advisory committee (N=20) consisting
22 of cancer patients/survivors (n=10, 5 of each) and healthcare providers (n=10), 2) design a cancer-specific
23 meditation app prototype, and 3) beta-test the prototype in cancer patients/survivors (N=30).
24 A standalone meditation app designed for and tested by cancer patients/survivors, leveraging a popular
25 and validated meditation app platform, to be made commercially available, is innovative and could provide a
26 scalable, highly engaging symptom-management tool that addresses cancer patients/survivors’ unique needs.
27 If our key feasibility milestones are met, we will further refine the cancer-specific app and conduct a randomized
28 controlled trial to determine the app’s long-term efficacy in reducing symptom burden in cancer patients/survivors
29 (Phase 2) that can later be commercialized and marketed to cancer patients/survivors, healthcare providers, and
30 clinics. (Phase 3).
